Proteomics analysis reveals that c-Jun signaling is crucial for apoptosis in melanoma treated with cytidine analogs, suggesting potential therapeutic implications.
Key Points
The activation of the JNK/c-Jun network promotes apoptosis in melanoma treated with cytidine analogs, enhancing our understanding of cancer treatment.
GEM treatment led to significant alterations in protein networks related to mitochondrial function and cell cycle arrest, critical for melanoma cell response.
Co-treatment with the JNK inhibitor JNKi increased cell survival, indicating the significant role of c-Jun signaling modulation in chemotherapeutic effects.
Proteomics analysis provides insights into the dual roles of chemotherapeutics in both promoting cell death and mediating resistance in melanoma cells.